What TV doesn't, print can't; we deliver.
What TV doesn't, print can't; we deliver.
Indian Council of Medical Research (ICMR) and the Madras Diabetes Research Foundation (MDRF) have joined forces to establish India’s first diabetes biobank in Chennai.
NEW DELHI: In a groundbreaking step towards addressing the escalating diabetes crisis, the Indian Council of Medical Research (ICMR) and the Madras Diabetes Research Foundation (MDRF) have joined forces to establish India’s first diabetes biobank in Chennai. This cutting-edge facility is designed to collect, store, and manage biological samples from diabetes patients nationwide, laying the foundation for transformative research.
The biobank, located at MDRF, aims to facilitate the study of genetic, environmental, and lifestyle factors contributing to diabetes, which affects over 70 million Indians. These insights will enable researchers to decode the complexities of diabetes and develop personalized treatment approaches, addressing India’s unique diabetes burden.
ALSO READ: Zakir Hussain: Lifetime of achievements that redefined rhythm
One of the key objectives of the biobank is to support research on diabetes-related complications, including cardiovascular diseases, neuropathy, and nephropathy, which are prevalent among the Indian population. The facility will also empower scientists to explore new diagnostic methods and targeted therapies by leveraging advancements in molecular biology, genomics, and precision medicine.
The collaboration between ICMR and MDRF reflects a national commitment to addressing the diabetes epidemic, which has become a major public health challenge. Experts have highlighted that lifestyle changes, urbanization, and genetic predispositions are fueling the rise in diabetes cases, making innovative research an urgent necessity. The biobank, equipped with state-of-the-art infrastructure, is expected to significantly enhance India’s capacity to tackle these issues.
ALSO READ: Legendary tabla virtuoso Zakir Hussain dies at 73, world mourns musical icon
The establishment of this facility also positions India as a global player in diabetes research, fostering collaborations with international institutions and attracting investments in healthcare innovation. By enabling cross-disciplinary studies, the biobank will bridge critical gaps in understanding diabetes and its complications, potentially benefiting millions of patients worldwide.
Dr. V. Mohan, chairman of MDRF, emphasized the importance of the initiative, noting that the biobank will not only enhance the scope of research but also contribute to policy-making and healthcare strategies aimed at diabetes prevention and management. He expressed optimism about the long-term impact of the facility on improving public health outcomes in India.
As diabetes continues to rise in prevalence, the biobank represents a significant step forward in combating the disease. By fostering innovation and collaboration, this initiative offers hope for better management and prevention of diabetes, setting a precedent for addressing other chronic diseases in the future.
